부가기능
The Biology Behind - The Battle between Tumor Suppressors: Is Gene Therapy Using p16INK4a More Efficacious Than p53 for Treatment of Ovarian Carcinoma? . Commentary re: S. C. Modesitt et al., In Vitro and In Vivo Adenovirus-mediated p53 and p16 Tumor Suppressor Therapy in Ovarian Cancer. Clin. Cancer Res., 7: 1765-1772, 2001./
기사 상세정보
서평
서평등록 중 오류가 발생하였습니다. 재시도 하십시오.